The Therapeutic Goods
Administration has issued
updated safety information on
the risk of bleeding associated
with Pradaxa (dabigatran).The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 27 May 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 13
WITH close to half of Australians expected to experience a mental illness at some stage of their life, research conducted by Griffith University found consumers believe community pharmacists are well placed to provide mental health promotion.